Subscribe to FREE newsletter
Bizcommunity.com - Daily medical industry news
Country:
Industry:
Ethical medicines news
Warnings about ‘over-use' of paracetamol

A panel of experts in the United States has raised new concerns about the popular painkiller paracetamol and are calling for the Food and Drug Administration (FDA) to reduce the maximum dose of paracetamol allowed because they say 'over-use' can cause serious liver damage. 6 Jul 2009 07:18


Scientists urge WHO to discredit homeopathy

In an open letter to the World Health Organisation a group of British scientists have asked for homeopathy to be publicly discredited as a treatment for serious diseases. The scientists fear vulnerable patients are dying from diseases such as HIV, malaria and tuberculosis because they are using homeopathic drugs instead of scientifically-tested medicines. 2 Jun 2009 15:12




FDA warns 14 pharmaceutical companies about short internet ads lacking risk information

The US government's Federal Drug Administration (FDA) has warned 14 major pharmaceutical firms about brief Internet advertisements that could have misled patients because they did not include information about health risks related to the drugs, according to letters posted to the agency's Web site Friday, the Wall Street Journal reports. 7 Apr 2009 06:55


Aiming for safer non-US-made medicines

FDA launches pilot program to improve drug safety and active drug ingredients produced outside US. 19 Jan 2009 07:06


FDA approves drug for patients with advanced prostate cancer

The US Food and Drug Administration recently approved the injectable drug degarelix, the first new drug in several years for prostate cancer. 14 Jan 2009 06:58




FDA mandates increased warnings for epilepsy drugs, stops short of issuing black box

The U.S. FDA has increased label warnings for epilepsy drugs, noting the increased risk of suicidal thoughts and behaviours, after a panel review earlier this year. 18 Dec 2008 07:33


Surface analysis exposes counterfeit medicines

CERAM Surface and Materials Analysis has published a white paper highlighting how surface analysis can expose counterfeit medicines. It describes how technologies such as X-ray photoelectron spectroscopy (XPS) and Time-of-Flight Secondary Ion Mass Spectroscopy (ToFSIMS) are being used in novel ways to not only analyse the composition of various pharmaceuticals, but also to determine differences in the manufacturing processes involved. 23 Oct 2008 07:25


‘Emerging 8' set to join ‘Big 5' targeted cancer therapy blockbusters

[Dr. Tom Gray] Since the first approval of a targeted therapy for cancer just over ten years ago, targeted therapies have notably improved treatment outcomes in cancer, becoming the leading therapy class in the oncology market. 3 Oct 2008 06:14


New single dose sachet for cough relief on the go

Benylin is launching a new single dose cough syrup sachet for a convenient and effective remedy when you're on the run. 22 Aug 2008 06:09


The need for lifecycle management

[Dr. Tijana Ignjatovic] Is drug lifecycle management the answer to the $100 billion question? 6 Aug 2008 07:47


Cote d'Ivoire: High prices drive people to counterfeit medicines

With a severe respiratory infection and a prescription for medicines that would cost 35,000 CFA francs (US$83) at official prices, Drissa Kone has a problem - he has no hope of raising enough money to buy the medicines. 8 Jul 2008 06:57


Medicine prices: Americans count the cost

New USA Today/Kaiser/Harvard poll finds the public sees real benefits from prescription medicines, but feels that they cost too much and that pharmaceutical companies care too much about profits. 6 Mar 2008 06:18


Problems with blood thinning drug could originate in China

Following a warning from the U.S. Food and Drug Administration (FDA) that it had received reports of 4 deaths and over 300 incidents of health problems associated with a blood-thinning drug, it has now been revealed that U.S. regulators never inspected the Chinese plant that makes Baxter International's heparin. 15 Feb 2008 07:55


News for medical professionals

New anti-thrombotic compound AVE5026 shows highly significant dose response in TREK phase IIb study 14 Dec 2007 08:53

Next page>>

Latest jobs

        

Weather

Other industry news

Receive free email newsletter
 
Tell a friend about us
 
All rights reserved. © 2009. Bizcommunity.com, its sponsors, contributors and advertisers disclaim all liability for any loss, damage, injury or expense that might arise from the use of, or reliance upon, the services contained herein. Privacy policy, Terms of Use.
 ADSL & Web hosting proudly provided by Afrihost.